Cancer Letters
Volume 238, Issue 2 , Pages 210-223 , 18 July 2006

P53 Codon 72 polymorphisms: A case-control study of gastric cancer and potential interactions

  • James Sul

      Affiliations

    • Clinical Instructor, Division of Digestive Diseases, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, 44-138 CHS, Los Angeles, CA 90095-1684, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 (310) 206 0517; fax: +1 (310) 825 1700.
    • ,
  • Guo-Pei Yu

      Affiliations

    • Biostatistics and Epidemiology Service, New York Eye and Ear Infirmary, New York, NY 10003
    • ,
  • Qing-Yi Lu

      Affiliations

    • Center for Human Nutrition, UCLA School of Medicine, Los Angeles, CA 90095, USA
    • ,
  • Ming-Lan Lu

      Affiliations

    • Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    • ,
  • Veronica Wendy Setiawan

      Affiliations

    • Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA
    • ,
  • Ming-Rong Wang

      Affiliations

    • Yangzhong County Anti-Epidemic Station, Yangzhong County, P.R. of China
    • ,
  • Chun Hua Guo

      Affiliations

    • Yangzhong County Anti-Epidemic Station, Yangzhong County, P.R. of China
    • ,
  • Shun-Zhang Yu

      Affiliations

    • Department of Epidemiology, School of Public Health, Fudan University, Shanghai, China
    • ,
  • Lina Mu

      Affiliations

    • Department of Epidemiology, School of Public Health, Fudan University, Shanghai, China
    • ,
  • Lin Cai

      Affiliations

    • Department of Epidemiology and Biostatistics, School of Public Health, Fijian Medical University, Fuzhou, Fujian, China
    • ,
  • Robert C Kurtz

      Affiliations

    • Gastroenterology and Nutrition Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021
    • ,
  • Zuo-Feng Zhang

      Affiliations

    • Department of Epidemiology, UCLA School of Public Health, and Jonsson Comprehensive Cancer Center, Los Angeles, CA 90095, USA

Received 20 November 2004 ,Revised 6 July 2005 ,Accepted 8 July 2005.

References 

  1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int. J. Cancer. 2001;94:153–156
  2. Devesa SS, Fraumeni F. J. Natl. Cancer Inst. 1999;91:747–749
  3. Cancer Facts & Figures 2003.
  4. Tahara E. Molecular mechanism of stomach carcinogenesis. J. Cancer Res. Clin. Oncol. 1993;119:265–272
  5. Neugut AI, Hayek M, Howe G. Epidemiology of gastric cancer. Semin. Oncol. 1996;23:281–291
  6. Mayne ST, Navarro SA. Diet, obesity and reflux in the etiology of adenocarcinomas of the esophagus and gastric cardia in humans. J. Nutr. 2002;132:3467S–3470S
  7. Chen MJ, Chiou YY, Wu DC, Wu SL. Lifestyle habits and gastric cancer in a hospital-based case-control study in Taiwan. Am. J. Gastroenterol. 2000;95:3242–3249
  8. Palli D, Russo A, Decarli A. Dietary patterns, nutrient intake and gastric cancer in a high-risk area of Italy. Cancer Causes Control. 2001;12:163–172
  9. Terry P, Lagergren J, Ye W, Wolk A, Nyren O. Inverse association between intake of cereal fiber and risk of gastric cardia cancer. Gastroenterology. 2001;120:387–391
  10. Hohenberger P, Gretschel S. Gastric cancer. Lancet. 2003;362:305–315
  11. Kelley JR, Duggan JM. Gastric cancer epidemiology and risk factors. J. Clin. Epidemiol. 2003;56:1–9
  12. Setiawan VW, Zhang ZF, Yu GP, Lu QY, Li YL, Lu ML, et al. Protective effect of green tea on the risks of chronic gastritis and stomach cancer. Int. J. Cancer. 2001;92:600–604
  13. Levine AJ. The p53 tumour suppressor gene and product. Cancer. Surv. 1992;12:59–79
  14. Gabbert HE, Muller W, Schneiders A, Meier S, Hommel G. The relationship of p53 expression to the prognosis of 418 patients with gastric carcinoma. Cancer. 1995;76:720–726
  15. Matozaki T, Sakamoto C, Suzuki T, Matsuda K, Uchida T, Nakano O, et al. p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells. Cancer Res. 1992;52:4335–4341
  16. Shepherd T, Tolbert D, Benedetti J, Macdonald J, Stemmermann G, Wiest J, et al. Alterations in exon 4 of the p53 gene in gastric carcinoma. Gastroenterology. 2000;118:1039–1044
  17. Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol. Cell. Biol. 1999;19:1092–1100
  18. Wang YC, Lee HS, Chen SK, Chang YY, Chen Y. Prognostic significance of p53 codon 72 polymorphism in lung carcinomas. Eur. J. Cancer. 1999;35:226–230
  19. Birgander R, Sjalander A, Zhou Z, Fan C, Beckman L, Beckman G. p53 polymorphisms and haplotypes in nasopharyngeal cancer. Hum. Hered. 1996;46:49–54
  20. Kawajiri K, Nakachi K, Imai K, Watanabe J, Hayashi S. Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer. Carcinogenesis. 1993;14:1085–1089
  21. Jin X, Wu X, Roth JA, Amos CI, King TM, Branch C, et al. Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. Carcinogenesis. 1995;16:2205–2208
  22. Papadakis EN, Dokianakis DN, Spandidos A. p53 codon 72 polymorphism as a risk factor in the development of breast cancer. Mol. Cell Biol. Res. Commun. 2000;3:389–392
  23. Sjalander A, Birgander R, Hallmans G, Cajander S, Lenner P, Athlin L, et al. p53 polymorphisms and haplotypes in breast cancer. Carcinogenesis. 1996;17:1313–1316
  24. Dokianakis DN, Spandidos A. P53 codon 72 polymorphism as a risk factor in the development of HPV-associated cervical cancer. Mol. Cell Biol. Res. Commun. 2000;3:111–114
  25. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature. 1998;393:229–234
  26. Hiyama T, Tanaka S, Kitadai Y, Ito M, Sumii M, Yoshihara M, et al. p53 Codon 72 polymorphism in gastric cancer susceptibility in patients with Helicobacter pylori-associated chronic gastritis. Int. J. Cancer. 2002;100:304–308
  27. Zhang ZW, Newcomb P, Hollowood A, Feakins R, Moorghen M, Storey A, et al. Age-associated increase of codon 72 arginine p53 frequency in gastric cardia and non-cardia adenocarcinoma. Clin. Cancer Res. 2003;9:2151–2156
  28. Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann. Intern. Med. 1999;130:883–890
  29. Thompson HJ, Zhu Z, Jiang W. Protection against cancer by energy restriction: all experimental approaches are not equal. J. Nutr. 2002;132:1047–1049
  30. Jacobs EJ, Connell CJ, McCullough ML, Chao A, Jonas CR, Rodriguez C, et al. Vitamin C, vitamin E, and multivitamin supplement use and stomach cancer mortality in the cancer prevention study II cohort. Cancer Epidemiol. Biomarkers Prev. 2002;11:35–41
  31. You WC, Zhang L, Gail MH, Chang YS, Liu WD, Ma JL, et al. Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. J. Natl. Cancer. Inst. 2000;92:1607–1612
  32. Stahelin HB, Gey KF, Eichholzer M, Ludin E, Bernasconi F, Thurneysen J, et al. Plasma antioxidant vitamins and subsequent cancer mortality in the 12-year follow-up of the prospective basel study. Am. J. Epidemiol. 1991;133:766–775
  33. Correa P, Fontham ET, Bravo JC, Bravo LE, Ruiz B, Zarama G, et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. J. Natl. Cancer. Inst. 2000;92:1881–1888
  34. Drake IM, Davies MJ, Mapstone NP, Dixon MF, Schorah CJ, White KL, et al. Ascorbic acid may protect against human gastric cancer by scavenging mucosal oxygen radicals. Carcinogenesis. 1996;17:559–562
  35. Sierra R, Chinnock A, Ohshima H, Pignatelli B, Malaveille C, Gamboa C, et al. In vivo nitrosoproline formation and other risk factors in Costa Rican children from high- and low-risk areas for gastric cancer. Cancer Epidemiol. Biomarkers Prev. 1993;2:563–568
  36. Mannick EE, Bravo LE, Zarama G, Realpe JL, Zhang XJ, Ruiz B, et al. Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res. 1996;56:3238–3243
  37. Zatonski W, Ohshima H, Przewozniak K, Drosik K, Mierzwinska J, Krygier M, et al. Urinary excretion of N-nitrosamino acids and nitrate by inhabitants of high- and low-risk areas for stomach cancer in Poland. Int. J. Cancer. 1989;44:823–827

PII: S0304-3835(05)00661-0

doi: 10.1016/j.canlet.2005.07.004

Cancer Letters
Volume 238, Issue 2 , Pages 210-223 , 18 July 2006

Article Tools